Xander van Wijk

PhD, DABCC, FADLM, SC(ASCP)

Specialties: Clinical Chemistry, Molecular Diagnostics, Pharmacogenomics, Toxicology, Mass Spectrometry. Dr. van Wijk is passionate about improving healthcare through innovative solutions. He is well-versed in working in regulated environments (CLIA/CAP/COLA, FDA) and has validated numerous laboratory-developed tests (LDTs) in, for example, molecular diagnostics (pharmacogenomics, molecular microbiology) and mass spectrometry (hormones, toxicology, TDM). He has functioned as a high-complexity CLIA laboratory director, technical supervisor and/or clinical consultant for a wide variety of clinical laboratories. He holds multiple board and leadership positions (e.g., ADLM, CLSI) and has a strong track record of scientific contributions with 75+ peer-reviewed articles, book chapters, and podium presentations. He has received several recent major national awards & recognitions, including the prestigious ADLM Academy George Grannis Award. Dr. van Wijk is board-certified by the American Board of Clinical Chemistry, and by the American Society of Clinical Pathology Board of Certification. He has served as Senior Medical Director at Beckman Coulter Diagnostics where he supported medical strategy, innovation, and new product development & launch, and as Assistant Professor of Pathology at the University of Chicago where he oversaw the Clinical Chemistry, Mass Spectrometry, Blood Gas, and Pharmacogenomics Laboratories as an attending clinical chemist.

Nationwide